Kamal joined the Li lab in 1999, very shortly after it was established, and in the years since has played an integral role in preclinical development and testing of TCM herbal formulas for food allergy and asthma. She is Manager of Scientific Affairs at Elysium Health, and a consultant to General Nutraceutical Technology, LLC and Assistant Professor in the Department of Microbiology and Immunology at New York Medical College. She received her bachelor’s degree from Queens College of The City University of New York and PhD from the Graduate School of Biomedical Sciences at Mount Sinai. She has been the lead scientist on several animal model studies evaluating herbal formulas such as ASHMI and FAHF-2, which moved on to clinical trials, and has been lead author on several key manuscripts resulting from these studies. Her current projects include development and testing of novel nanoparticle and herbal solutions for delivery of Berberine for reduction of IgE and preclinical research into combination TCM/OIT therapy for food allergy. She is also the author, with Xiu-Min Li, of a chapter called “Mechanism of Eczema, Biomarkers, and Perspectives of TCM Therapeutic Targets” in the new book, Treating Eczema with Traditional Chinese Medicine.